Experimental anti-aging drug successfully tested in humans

One of the theories about gaining control over the aging of the body says that you need to learn how to remove “senile cells” from it in time. These are damaged cells that are no longer able to divide, which still take part in the life of tissues and provoke negative reactions. If you remove them, the situation will return to normal, as the irritation factor will disappear.

A group of researchers led by Nicholas Musi of the University of Texas at Austin conducted an experiment on 14 patients with idiopathic pulmonary fibrosis. They used drugs that are used to fight cancer cells in leukemia by developing a combination of dasatinib and querticin. Within three weeks, the subjects received nine doses of this "medicine", after which they showed clear signs of improving their well-being.

There is no talk of a complete recovery of the experimental group, the researchers only tested the very concept of the possibility of a therapeutic effect on decrepit cells. The results are considered promising, so several new experiments have already been launched. In one, a modified version of the anti-aging drug combination is given to people with lung disease, in the other, those with chronic kidney disease.

Most of all, scientists are afraid of side effects, since they cannot calculate all the consequences of removing dying cells. Therefore, experiments are carried out on those patients who already have almost nothing to lose. But if the work is crowned with success, it will be possible to count on the rapid development of a universal "pill against old age" for everyone. Or at least it will make old age less painful and uncomfortable.